StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.72+0.06 (+3.61%)

Close on Nov 18, 2026Market cap $4.37MP/E –Yield –

Alaunos Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Alaunos Therapeutics's price to sales ratio was 456.4× on Jul 31, 2025, against 46.9× a year earlier. Over the last 4 years it ranged from 6.6× to 494.7×, with a median of 235.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 2025456.4×+449.8
2023Oct 31, 20236.6×−275.6
2022May 31, 2022282.1×+99.2
2019Jan 31, 2019183.0×+30.2
2018Dec 31, 2018152.8×−298.0
2014Apr 30, 2014450.7×−3.3
2013Dec 31, 2013454.0×+40.0
2012Dec 31, 2012414.0×–

More Alaunos Therapeutics figures

See a number that looks wrong?